Pineridge Advisors LLC Corcept Therapeutics Inc Transaction History
Pineridge Advisors LLC
- $350 Billion
- Q3 2025
A detailed history of Pineridge Advisors LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Pineridge Advisors LLC holds 50 shares of CORT stock, worth $3,686. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$3,686% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
483Shares Held
84.1MCall Options Held
490KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.54MShares$703 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.7MShares$567 Million20.92% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$462 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$285 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.9B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...